Michael Mega
Neurology · Portland, ORNPI 1437186038
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Biogen accounts for 98.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $6,860 and has fallen 99.7% since, to $20 in 2024.
Across 10 payments — averaging $1172.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$12K
- Novo Nordisk$65
- Lilly USA, LLC$61
Across 338 payments — averaging $7296.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.7M
- Eisai Inc.$651K
- Novo Nordisk AS$65K
- Janssen Research & Development, LLC$14K
- Biogen$11K
- Genentech, Inc.$700
- plus $319 from 2 others
What the payments were for
- Consulting fees$4,80841%
- Speaking & faculty fees$6,78058%
- Food & beverage$771%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 5 | $11,604 |
| Novo Nordisk | 2 | $65 |
| Lilly USA, LLC | 3 | $61 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADUHELM$3,678
How this compares
$11,729 in reported general payments places this provider in the 85th percentile of 228 neurology providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 30 | $3,299 |
| Donepezil Hcl | 36 | $199 |
| Citalopram HbrCitalopram Hydrobromide | 21 | $111 |
Paid to pharmacies, not to this prescriber.
Other neurology in Portland
- Kyle SmootPortland$932K
- Chafic KaramPortland$727K
- Herbert KrobPortland$416K
- Stanley CohanPortland$334K
- Matthew BrodskyPortland$123K
- Delaram SafarpourPortland$77K
- Kiren Kresa-ReahlPortland$71K
- Nizar ChahinPortland$57K
- Jeffrey KayePortland$54K
- Michelle CameronPortland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.